Ipamorelin evidence check
Ipamorelin increases growth hormone release in human volunteers.
Verdict
Supported with an evidence grade of B. A narrow human volunteer biomarker claim is supported. This does not prove body-composition, recovery, anti-aging, or self-use claims.
What this means
This grade applies only to the claim on this page, including the stated population and outcome. A supported claim in one context should not be stretched into a broader peptide promise.
What this does not mean
This page is not dosing guidance, a protocol, a recommendation to buy or use a product, or personal medical advice. High-risk claims need narrow wording, source links, and human review before publication.
Source trail
Evidence is listed by source type so you can see whether the claim rests on labeling, human studies, preclinical work, anecdotes, or vendor language.
Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers.
Candidate PubMed evidence for Ipamorelin / injury recovery: Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers. Journal: Pharmaceutical research. This source supports evidence review and should not be treated as dosing guidance or personalized medical advice.
Open sourceStructure-activity relationship for peptidic growth hormone secretagogues.
Review source for growth-hormone secretagogue class context; not proof of consumer outcome claims.
Open sourceDisclosure
Disclosure: Some links may be affiliate links. Peptide Fact Checks may earn a commission if you use them. That does not affect evidence grades, verdicts, or vendor transparency notes.